Aprea Therapeutics Inc (APRE)
4.30
+0.07
(+1.65%)
USD |
NASDAQ |
Jun 14, 11:09
Aprea Therapeutics Accounts Payable (Quarterly): 1.318M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.318M |
| December 31, 2023 | 1.670M |
| September 30, 2023 | 0.8626M |
| June 30, 2023 | 1.131M |
| March 31, 2023 | 0.826M |
| December 31, 2022 | 0.8428M |
| September 30, 2022 | 1.136M |
| June 30, 2022 | 3.990M |
| March 31, 2022 | 1.988M |
| December 31, 2021 | 1.773M |
| September 30, 2021 | 2.548M |
| Date | Value |
|---|---|
| June 30, 2021 | 2.361M |
| March 31, 2021 | 3.457M |
| December 31, 2020 | 4.504M |
| September 30, 2020 | 4.35M |
| June 30, 2020 | 5.443M |
| March 31, 2020 | 3.007M |
| December 31, 2019 | 2.177M |
| September 30, 2019 | 3.510M |
| June 30, 2019 | 2.324M |
| December 31, 2018 | 1.739M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.826M
Minimum
Mar 2023
5.443M
Maximum
Jun 2020
2.461M
Average
2.250M
Median
Accounts Payable (Quarterly) Benchmarks
| Stoke Therapeutics Inc | 2.102M |
| NovaBay Pharmaceuticals Inc | 1.117M |
| Palatin Technologies Inc | 3.443M |
| iBio Inc | 1.228M |
| Theriva Biologics Inc | 0.571M |